Skip to content

Clinical observation on the therapeutic effect of repeated needling for frozen shoulder periarthritis

Clinical observation on the therapeutic effect of repeated needling for frozen shoulder periarthritis

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400079437
Enrollment
Unknown
Registered
2024-01-03
Start date
2024-01-31
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frozen period of shoulder periarthritis

Interventions

Test group:Acupoint selection: Ashi acupoint, Jian Yu, Jian Zhen, Jian Liao Operation: The patient takes a sitting position, and the physician holds the patient s shoulder to make active and passive m
Control group:Acupoint selection: Ashi acupoint, Jian Yu, Jian Zhen, Jian Liao Operation: Routine disinfection of Ashi acupoint, Jian Yu, Jian Zhen, Jian Liao, using 0.25 × The 40mm sterile acupunctur

Sponsors

China Aerospace Science & Industry Corporation 731 Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Meets the diagnostic criteria for shoulder periarthritis; (2) Age range from 40 to 60 years old; (3) The course of the disease ranges from 1 month to 24 months; (4) 2 = VAS score = 8 points; (5) Voluntarily cooperate with acupuncture treatment and sign an informed consent form. Only those who meet the above five criteria can be included.

Exclusion criteria

Exclusion criteria: (1) Merge shoulder pain related diseases, such as shoulder trauma, rotator cuff injury, herpes zoster, etc; (2) Shoulder pain caused by systemic diseases, such as rheumatoid arthritis, ankylosing spondylitis, etc; (3) Have taken medication to alleviate shoulder periarthritis in the past 2 months, or have received non pharmacological therapy; (4) Concomitant severe cardiovascular disease, cerebrovascular disease, liver and kidney dysfunction, hematological system disease, and mental illness; (5) There are any contraindications of acupuncture and moxibustion, scars or infections at the application site, or the researchers think that there are systemic diseases at the application site that are not suitable for taking measures; (6) Participants in other clinical trials. Those who meet any of the above criteria cannot be included in the group.

Design outcomes

Primary

MeasureTime frame
VAS scores;Shoulder joint constant score;

Secondary

MeasureTime frame
Daily living ability score;

Countries

China

Contacts

Public ContactYang Zhang

China Aerospace Science & Industry Corporation 731 Hospital

2779114774@qq.com+86 139 3157 0486

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026